Newstral
Article
The Hindu on 2020-12-11 03:06
U.S. panel recommends authorisation of Pfizer-BioNTech coronavirus vaccine
Related news
- FDA advisory panel recommends use of Pfizer vaccinePOLITICO
- Coronavirus live updates | Govt panel recommends emergency use authorisation to Zydus Cadila's 3-dose Covid vaccineThe Hindu
- EU approves Pfizer-BioNTech coronavirus vaccineThe Hindu
- Pfizer seeks emergency use authorisation for its COVID-19 vaccine in IndiaThe Hindu
- FDA Panel Recommends Emergency Authorization of Pfizer Coronavirus Vaccineslate.com
- Pfizer withdraws Emergency Use Authorisation application for its COVID-19 vaccine in IndiaThe Hindu
- FFDA panel debates authorisation of Pfizer/BioNTech vaccineft.com
- FDA Advisory Panel Takes Up Pfizer-BioNTech Vaccinewsj.com
- FDA panel recommends booster shot of Johnson & Johnson COVID vaccineoregonlive.com
- UK approves Pfizer-BioNTech COVID-19 vaccine for useThe Hindu
- Pfizer-BioNTech files for U.S. approval of COVID-19 vaccineamny.com
- US panel endorses widespread use of Pfizer COVID-19 vaccineWRAL
- Pfizer coronavirus vaccine gets endorsement from U.S. government panelcleveland.com
- Advisory Panel Recommends Approval of Pfizer COVID-19 Vaccine in U.S.variety.com
- Govt panel recommends emergency use authorisation for Corbevax for 5-11 age groupThe Hindu
- CDC panel recommends avoiding J&J vaccine in favor of Pfizer, Moderna shots due to clotting riskdailyherald.com
- Pfizer and German partner BioNTech seeking emergency use of COVID-19 vaccine in USAlaska Dispatch News